Answers are grounded in this paper and cite their sources.
Four of 10 patients who were enrolled on protocols of high-dose immunosuppression with peripheral blood stem cell rescue for MS experienced neurologic worsening while receiving recombinant human granulocyte colony-stimulating factor. There was improvement when methylprednisolone was given to three of the patients, but one patient died of respiratory failure. The mechanism of the neurologic worsening is uncertain.
No takes yet. Share an insight, caveat, or question.
Openshaw et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: